Trial Details
COMPLETEDBasic Information
| Clinical ID | c2752 |
|---|---|
| Identifier | NCT03009396 |
| Trial Title | Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine) |
Participant Information
| Sponsor | RedHill Biopharma Limited |
|---|---|
| City | San Carlos |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2017-03-18 |
|---|---|
| Primary Completion Date | 2018-11-13 |
| Completion Date | 2019-08-19 |